DiGeorge Syndrome Critical Region Gene 8 (DGCR8) Peptid
DGCR8
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle DGCR8 Produkte
- DGCR8 (DiGeorge Syndrome Critical Region Gene 8 (DGCR8))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- DKKDEENELD QEKRVEYAVL DELEDFTDNL ELDEEGAGGF TAKAIVQRDR
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of DGCR8 antibody,
Alternative Names: DGCR8 control peptide, DGCR8 antibody Blocking Peptide, Anti-DGCR8 Blocking Peptide, Digeorge Syndrome Critical Region Gene 8 Blocking Peptide, C22orf12 Blocking Peptide, DGCRK6 Blocking Peptide, Gy1 Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- DGCR8 (DiGeorge Syndrome Critical Region Gene 8 (DGCR8))
- Synonyme
- MGC78846 Peptide, DGCR8 Peptide, gy1 Peptide, dgcrk6 Peptide, C22orf12 Peptide, DGCRK6 Peptide, Gy1 Peptide, pasha Peptide, D16H22S1742E Peptide, D16H22S788E Peptide, D16Wis2 Peptide, N41 Peptide, Vo59c07 Peptide, si:ch211-106a19.4 Peptide, wu:fc23f08 Peptide, wu:fc38f06 Peptide, DGCR8 microprocessor complex subunit L homeolog Peptide, DiGeorge syndrome critical region gene 8 Peptide, DGCR8 microprocessor complex subunit Peptide, DGCR8, microprocessor complex subunit Peptide, microRNA 3618 Peptide, dgcr8.L Peptide, DGCR8 Peptide, dgcr8 Peptide, Dgcr8 Peptide, MIR3618 Peptide
- Hintergrund
- DGCR8 contains 2 DRBM (double-stranded RNA-binding) domains and 1 WW domain. It may play a part in the etiology of the velocardiofacial/DiGeorge syndrome (VCFS/DGS), a developmental disorder characterized by structural and functional palate anomalies, conotruncal cardiac malformations, immunodeficiency, hypocalcemia, and typical facial anomalies.
- Molekulargewicht
- 85 kDa
-
Sie sind hier:
